Press Releases

/Press Releases
19 01, 2017

ADARZA BIOSYSTEMS CLOSES ON $17 MILLION SERIES C FINANCING

By |January 19th, 2017|Adarza News, Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development [...]

24 03, 2016

Adarza BioSystems Completes $5 M Series-B Closing

By |March 24th, 2016|Adarza News, Adarza Timeline, Press Releases|0 Comments

ROCHESTER, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable [...]

25 11, 2014

Horizon Discovery Group plc and Adarza BioSystems Enter Supply & Licensing Agreement

By |November 25th, 2014|Adarza News, Adarza Timeline, Press Releases|0 Comments

Agreement gives Horizon exclusive right to supply services on Ardaza’s multiplex label-free immunoassay technology.

1 10, 2014

Adarza BioSystems Completes $6.8M Series-A Financing

By |October 1st, 2014|Adarza News, Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY:  Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed the final tranche of its Series-A financing bringing the total Series-A financing amount to $6.8 million. Proceeds from the financing will be used to launch its first 100-plex immunoassay product consumable and instrument and accelerate [...]

17 04, 2013

BioGenerator Investment Helps Adarza BioSystems Establish Operations in St. Louis

By |April 17th, 2013|Adarza Timeline, Press Releases|0 Comments

Life Science company expands presence to St. Louis ST. LOUIS, MO:  BioGenerator recently led syndication of investment in Adarza BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, Adarza will conduct its primary business and product development in St. Louis as well as its manufacturing activities. Adarza is [...]

4 02, 2013

Adarza BioSystems Awarded Federal Grant to Support Toxic Exposure Assessment Product Development

By |February 4th, 2013|Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $245,912 Small Business Innovation Research (SBIR) grant from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry (AIRTM) bioassay platform for the detection of environmental toxins in [...]

9 05, 2011

Adarza BioSystems Expands Its Board of Directors with Industry Leaders

By |May 9th, 2011|Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY: Adarza BioSystems, Inc. announced today that it has expanded its Board of Directors with the addition of two leading business executives: Dr. Heiner Dreismann, former CEO of Roche Molecular Systems and James Senall, President of High Tech Rochester. Dr. Dreismann brings a wealth of experience, contacts and insight to Adarza as it moves [...]

1 05, 2011

Diagnostic Industry Leader Heiner Dreismann Joins Adarza BioSystems Board of Directors

By |May 1st, 2011|Adarza Timeline, Press Releases|0 Comments

ROCHESTER, N.Y. – Adarza BioSystems, Inc. announced today that former Roche Molecular Systems CEO, Dr. Heiner Dreismann, an internationally recognized leader in the in vitro diagnostics industry, has joined Adarza’s Board of Directors. Dr. Dreismann brings a wealth of experience, contacts and insight to Adarza as it moves to commercialize its protein multiplex product platform [...]

8 11, 2010

Adarza BioSystems Awarded Federal Grant to Support Cancer Screening Product Development

By |November 8th, 2010|Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY:  Adarza BioSystems, Inc. has been awarded a $244,500 Qualifying Therapeutic Discovery Project grant from the Internal Revenue Service to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry bioassay platform to the diagnosis and monitoring of bladder cancer. The Qualifying Therapeutic Discovery Program was enacted as part of the [...]

1 09, 2009

Adarza Biosystems Awarded Phase II SBIR Grant to Support Environmental Exposure Assessment Product Development

By |September 1st, 2009|Press Releases|0 Comments

ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $1.8 million Small Business Innovation Research (SBIR) grant from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry (AIRTM) bioassay platform for the detection of blood [...]